We are live on ! Find out more
APYX icon

Apyx Medical

31 hedge funds and large institutions have $8.44M invested in Apyx Medical in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

11% more funds holding

Funds holding: 2831 (+3)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

30% less capital invested

Capital invested by funds: $12.1M → $8.44M (-$3.62M)

Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
6
Closed
1
Calls
Puts
Net Calls
Net Calls Change

APYX Hedge Fund Activity: Q1 2016 in Review

31 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2016, worth a combined $8.44M — down 30% from $12.1M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new APYX positions and 1 closed out — a net gain of 3 holders — while 6 added to existing stakes and 6 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $69.8K. The largest seller was Deerfield Management, exiting entirely with an estimated $1.45M sold.

  • 31 institutional investors held Apyx Medical (APYX) as of Q1 2016, up from 28 in Q4 2015.
  • Funds reported $8.44M of Apyx Medical stock for Q1 2016, down 30% quarter-over-quarter.
  • 4 funds opened new Apyx Medical positions in Q1 2016 and 1 closed out, a net change of +3 holders.
  • The largest Apyx Medical buyer in Q1 2016 was Renaissance Technologies, an estimated $69.8K added.
  • The largest Apyx Medical seller in Q1 2016 was Deerfield Management, an estimated $1.45M sold.

Based on aggregated 13F filings for Q1 2016.